Mario Cozzolino

InstitutionUniversity of Milan
AddressMilan
Italy
vCardDownload vCard
    Publication Timeline
    COVID-19 publications
    Bar chart showing 13 Covid-19 publications, with a maximum of 2 publications in August 2020 and January 2021 and February 2021
    All Publications
    Bar chart showing 197 publications over 20 distinct years, with a maximum of 20 publications in 2017
    These graphs show COVID-19 publications by month since August 2019 and all publications written by authors of COVID-19 publications over the past 30 years.

    To see the data from both graphs as text, click here.
    Publication Field Summary
    This graph shows the number and percent of publications by field. Fields are based on how the National Library of Medicine (NLM) classifies the publications' journals and might not represent the specific topics of the publications. Note that an individual publication can be assigned to more than one field. As a result, the publication counts in this graph might add up to more than the number of publications the person has written. To see the data as text, click here.
    Publication List
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications.
    Sort By:     Newest   |   Oldest   |   Most Cited   |   Most Discussed
    PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. Cassia MA, Casazza R, Napodano P, Cozzolino M. COVID-19 Infection and Acute Kidney Injury: Cause or Complication? Blood Purif. 2022; 51(3):288-291. PMID: 34107484.
      Citations:    Fields:    
    2. Coppola S, Cenci S, Cozzolino M, Chiumello D. Sevoflurane sedation and nephrogenic diabetes insipidus in patients affected with severe acute respiratory syndrome coronavirus 2. Eur J Anaesthesiol. 2021 04 01; 38(4):438-441. PMID: 33661827.
      Citations:    Fields:    Translation:Humans
    3. Podestà MA, Valli F, Galassi A, Cassia MA, Ciceri P, Barbieri L, Carugo S, Cozzolino M. COVID-19 in Chronic Kidney Disease: The Impact of Old and Novel Cardiovascular Risk Factors. Blood Purif. 2021; 50(6):740-749. PMID: 33752209.
      Citations: 2     Fields:    Translation:HumansAnimals
    4. Cozzolino M, Conte F, Zappulo F, Ciceri P, Galassi A, Capelli I, Magnoni G, La Manna G. COVID-19 pandemic era: is it time to promote home dialysis and peritoneal dialysis? Clin Kidney J. 2021 Mar; 14(Suppl 1):i6-i13. PMID: 33796282.
      Citations: 1     
    5. Galassi A, Magagnoli L, Cozzolino M. COVID-19 in a dialysis center in Milan from March to June 2020: understanding how to respond to the second wave of the pandemic. J Nephrol. 2021 02; 34(1):11-14. PMID: 33534068.
      Citations:    Fields:    Translation:HumansPHPublic Health
    6. Barassi A, Pezzilli R, Mondoni M, Rinaldo RF, DavÌ M, Cozzolino M, Melzi D'Eril GV, Centanni S. Vitamin D in severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) patients with non-invasive ventilation support. Panminerva Med. 2021 Jan 25. PMID: 33494567.
      Citations: 3     Fields:    
    7. Priori A, Baisi A, Banderali G, Biglioli F, Bulfamante G, Canevini MP, Cariati M, Carugo S, Cattaneo M, Cerri A, Chiumello D, Colosio C, Cozzolino M, D'Arminio Monforte A, Felisati G, Ferrari D, Gambini O, Gardinali M, Marconi AM, Olivari I, Orfeo NV, Opocher E, Pietrogrande L, Previtera A, Rossetti L, Vegni E, Toschi V, Zuin M, Centanni S. The Many Faces of Covid-19 at a Glance: A University Hospital Multidisciplinary Account From Milan, Italy. Front Public Health. 2020; 8:575029. PMID: 33490013.
      Citations: 9     Translation:Humans
    8. Galassi A, Casanova F, Gazzola L, Rinaldo R, Ceresa M, Restelli E, Giorgini A, Birocchi S, Giovenzana M, Zoni U, Valli F, Massironi L, Belletti S, Magagnoli L, Stucchi A, Ippolito M, Carugo S, Parazzini E, Cozzolino M. SARS-CoV-2-related ARDS in a maintenance hemodialysis patient: case report on tailored approach by daily hemodialysis, noninvasive ventilation, tocilizumab, anxiolytics, and point-of-care ultrasound. Clin Case Rep. 2020 Dec 04. PMID: 33362933.
      Citations: 2     
    9. Ronco C, Reis T, Cozzolino M. Rationale for Medium Cutoff Membranes in COVID-19 Patients Requiring Renal Replacement Therapy. Nephron. 2020; 144(11):550-554. PMID: 32750694.
      Citations: 1     Fields:    Translation:HumansCellsPHPublic Health
    10. Cozzolino M, Piccoli GB, Ikizler TA, Ronco C. The COVID-19 infection in dialysis: are home-based renal replacement therapies a way to improve patient management? J Nephrol. 2020 08; 33(4):629-631. PMID: 32542561.
      Citations: 5     Fields:    Translation:HumansCellsPHPublic Health
    11. Ippolito M, Di Tria GB, Aldrigo C, Ricci M, Zoni U, Giordano A, Cozzolino M. [Standard procedures in dialysis during the Covid-19 epidemic]. G Ital Nefrol. 2020 Jun 10; 37(3). PMID: 32530147.
      Citations: 1     Fields:    Translation:HumansCellsPHPublic Health
    12. Kliger AS, Cozzolino M, Jha V, Harbert G, Ikizler TA. Managing the COVID-19 pandemic: international comparisons in dialysis patients. Kidney Int. 2020 07; 98(1):12-16. PMID: 32471637.
      Citations: 19     Fields:    Translation:HumansCellsPHPublic Health
    13. Cozzolino M. ERA-EDTA sharing Milan experience on coronavirus management in dialysis centres. Clin Kidney J. 2020 Jun; 13(3):473-474. PMID: 32695329.
      Citations: 2     
    14. Bover J, Cozzolino M. Small steps towards the potential of 'preventive' treatment of early phosphate loading in chronic kidney disease patients. Clin Kidney J. 2019 Oct; 12(5):673-677. PMID: 31584564.
      Citations: 2     
    15. Cozzolino M, Ciceri P, Galassi A. Hyperphosphatemia: a novel risk factor for mortality in chronic kidney disease. Ann Transl Med. 2019 Feb; 7(3):55. PMID: 30906759.
      Citations: 7     
    16. Cozzolino M, Mangano M, Galassi A, Ciceri P, Messa P, Nigwekar S. Vitamin K in Chronic Kidney Disease. Nutrients. 2019 Jan 14; 11(1). PMID: 30646590.
      Citations: 10     Fields:    Translation:Humans
    17. Cozzolino M, Carrafiello G, Ierardi AM, Petrillo M, Coppola A, Angileri SA, Galassi A, Padovano B, Volpi A. Percutaneous microwave ablation of renal angiomyolipomas in tuberous sclerosis complex to improve the quality of life: preliminary experience in an Italian center. Radiol Med. 2019 Mar; 124(3):176-183. PMID: 30539412.
      Citations: 1     Fields:    Translation:Humans
    18. Jommi C, Armeni P, Battista M, di Procolo P, Conte G, Ronco C, Cozzolino M, Costanzo AM, di Luzio Paparatti U, Concas G, Remuzzi G. The Cost of Patients with Chronic Kidney Failure Before Dialysis: Results from the IRIDE Observational Study. Pharmacoecon Open. 2018 Dec; 2(4):459-467. PMID: 29623638.
      Citations: 6     
    19. Di Lullo L, Ronco C, Granata A, Paoletti E, Barbera V, Cozzolino M, Ravera M, Fusaro M, Bellasi A. Chronic Hyperkalemia in Cardiorenal Patients: Risk Factors, Diagnosis, and New Treatment Options. Cardiorenal Med. 2019; 9(1):8-21. PMID: 30359977.
      Citations: 4     Fields:    Translation:Humans
    20. Cozzolino M, Mangano M, Stucchi A, Ciceri P, Conte F, Galassi A. Cardiovascular disease in dialysis patients. Nephrol Dial Transplant. 2018 10 01; 33(suppl_3):iii28-iii34. PMID: 30281132.
      Citations: 66     Fields:    Translation:Humans
    21. Alfieri C, Regalia A, Zanoni F, Vettoretti S, Cozzolino M, Messa P. The Importance of Adherence in the Treatment of Secondary Hyperparathyroidism. Blood Purif. 2019; 47(1-3):37-44. PMID: 30223271.
      Citations: 6     Fields:    Translation:Humans
    22. Alfieri C, Malberti F, Mazzaferro S, Gallieni M, Russo D, Messa P, Cozzolino M. [Hyperphosphatemia in dialysis: which binder?] G Ital Nefrol. 2018 Sep; 35(5). PMID: 30234231.
      Citations:    Fields:    Translation:Humans
    23. Mazzaferro S, Tartaglione L, Cascone C, Di Daniele N, Pani A, Morosetti M, Francisco M, Nordio M, Leonardi M, Martello M, Grimaldi C, Cozzolino M, Rotondi S, Pasquali M. Multicenter study on parathyroidectomy (PTX) in Italy: preliminary results. J Nephrol. 2018 Oct; 31(5):767-773. PMID: 30155676.
      Citations: 1     Fields:    Translation:Humans
    24. Ureña-Torres PA, Vervloet M, Mazzaferro S, Oury F, Brandenburg V, Bover J, Cavalier E, Cohen-Solal M, Covic A, Drüeke TB, Hindié E, Evenepoel P, Frazão J, Goldsmith D, Kazama JJ, Cozzolino M, Massy ZA. Novel insights into parathyroid hormone: report of The Parathyroid Day in Chronic Kidney Disease. Clin Kidney J. 2019 Apr; 12(2):269-280. PMID: 30976408.
      Citations: 8     
    25. Cozzolino M, Bolasco P, Ronco C, Conte G, Menè P, Mereu MC, Di Luca M, Roccatello D, Rosati A, Jommi C, Costanzo AM, Gualberti G, di Luzio Paparatti U, Remuzzi G. Clinical Management of Chronic Kidney Disease Patients in Italy: Results from the IRIDE Study. Nephron. 2018; 140(1):39-47. PMID: 30016767.
      Citations: 3     Fields:    Translation:Humans
    26. Bellasi A, Cozzolino M, Malberti F, Cancarini G, Esposito C, Genderini A, Guastoni CM, Ondei P, Pontoriero G, Teatini U, Vezzoli G, Messa P, Locatelli F. [New scenarios in secondary hyperparathyroidism: etelcalcetide. Position paper of Nephrologists form Lombardy]. G Ital Nefrol. 2018 May; 35(3). PMID: 29786181.
      Citations:    Fields:    Translation:Humans
    27. Ureña-Torres PA, Cozzolino M, Bover J. [Utilization of alfacalcidol and active vitamin D analogs in chronic kidney disease]. Nephrol Ther. 2018 Jun; 14(4):189-200. PMID: 29545131.
      Citations: 1     Fields:    Translation:Humans
    28. Bover J, Ureña P, Aguilar A, Mazzaferro S, Benito S, López-Báez V, Ramos A, daSilva I, Cozzolino M. Alkaline Phosphatases in the Complex Chronic Kidney Disease-Mineral and Bone Disorders. Calcif Tissue Int. 2018 08; 103(2):111-124. PMID: 29445837.
      Citations: 8     Fields:    Translation:HumansAnimals
    29. Cianciolo G, Galassi A, Capelli I, Schillaci R, La Manna G, Cozzolino M. Klotho-FGF23, Cardiovascular Disease, and Vascular Calcification: Black or White? Curr Vasc Pharmacol. 2018 01 26; 16(2):143-156. PMID: 28294047.
      Citations: 14     Fields:    Translation:HumansAnimalsCells
    30. Cozzolino M, Messa P. Treatments for secondary hyperparathyroidism in hemodialysis. Pol Arch Intern Med. 2017 12 22; 127(12):807-809. PMID: 29272256.
      Citations:    Fields:    Translation:Humans
    31. Cozzolino M. Achieve Your Goals Together. The Easy and Reasonable Way to Treat Chronic Kidney Disease-Mineral Bone Disorder. Blood Purif. 2018; 45(1-3):71-72. PMID: 29241204.
      Citations:    Fields:    Translation:Humans
    32. Genovesi S, Nava E, Pasa A, Corghi E, Ondei P, Marta E, Bellasi A, Malberti F, Teatini U, Guastoni CM, Spatola L, Luise MC, Tiboldo R, Bertoli S, Messa P, Doria M, Gallieni M, Cozzolino M, Spotti D, Sala V, Sironi E, Boriani G. [Clinical practice for the diagnosis of cardiac arrhythmias in patients on renal replacement therapy: data from a Lombard survey]. G Ital Nefrol. 2017 Dec 05; 34(Nov-Dec). PMID: 29207228.
      Citations:    Fields:    Translation:Humans
    33. Covic A, Vervloet M, Massy ZA, Torres PU, Goldsmith D, Brandenburg V, Mazzaferro S, Evenepoel P, Bover J, Apetrii M, Cozzolino M. Bone and mineral disorders in chronic kidney disease: implications for cardiovascular health and ageing in the general population. Lancet Diabetes Endocrinol. 2018 04; 6(4):319-331. PMID: 29050900.
      Citations: 31     Fields:    Translation:Humans
    34. Cozzolino M. CKD-MBD KDIGO guidelines: how difficult is reaching the 'target'? Clin Kidney J. 2018 Feb; 11(1):70-72. PMID: 29423205.
      Citations: 3     
    35. Evenepoel P, D'Haese P, Bacchetta J, Cannata-Andia J, Ferreira A, Haarhaus M, Mazzaferro S, Lafage Proust MH, Salam S, Spasovski G, Cozzolino M. Bone biopsy practice patterns across Europe: the European renal osteodystrophy initiative-a position paper. Nephrol Dial Transplant. 2017 Oct 01; 32(10):1608-1613. PMID: 28339949.
      Citations: 13     Fields:    Translation:Humans
    36. Mazzaferro S, Massy ZA, Vervloet M, Cozzolino M. Bone in CKD: why the ERA EDTA CKD-MBD working group organized a dedicated meeting? J Nephrol. 2017 10; 30(5):621-622. PMID: 28942478.
      Citations:    Fields:    Translation:HumansAnimals
    37. Castini D, Persampieri S, Floreani R, Galassi A, Biondi ML, Carugo S, Cozzolino M. Troponin I Levels in Asymptomatic Hemodialysis Patients. Blood Purif. 2017; 44(3):236-243. PMID: 28957803.
      Citations: 1     Fields:    Translation:HumansCTClinical Trials
    38. Di Lullo L, Ronco C, Bellasi A, Cozzolino M, Floccari F, Barbera V, Verdesca S, Rivera R, De Pascalis A, Mudoni A, Santoro A. [Neprilysin inhibition and chronic kidney disease]. G Ital Nefrol. 2017 Sep 28; 34(5):102-112. PMID: 28963831.
      Citations: 1     Fields:    Translation:Humans
    39. Cozzolino M, Galassi A, Pivari F, Ciceri P, Conte F. The Cardiovascular Burden in End-Stage Renal Disease. Contrib Nephrol. 2017; 191:44-57. PMID: 28910790.
      Citations: 15     Fields:    Translation:Humans
    40. Galassi A, Bellasi A, Ciceri P, Pivari F, Conte F, Cozzolino M. Calcifediol to treat secondary hyperparathyroidism in patients with chronic kidney disease. Expert Rev Clin Pharmacol. 2017 Oct; 10(10):1073-1084. PMID: 28846459.
      Citations: 3     Fields:    Translation:HumansAnimals
    41. Giannini S, Mazzaferro S, Minisola S, De Nicola L, Rossini M, Cozzolino M. Raising awareness on the therapeutic role of cholecalciferol in CKD: a multidisciplinary-based opinion. Endocrine. 2018 02; 59(2):242-259. PMID: 28726185.
      Citations: 5     Fields:    Translation:Humans
    42. Cozzolino M, Galassi A, Conte F, Mangano M, Di Lullo L, Bellasi A. Treatment of secondary hyperparathyroidism: the clinical utility of etelcalcetide. Ther Clin Risk Manag. 2017; 13:679-689. PMID: 28615947.
      Citations: 7     
    43. Cozzolino M, Foque D, Ciceri P, Galassi A. Phosphate in Chronic Kidney Disease Progression. Contrib Nephrol. 2017; 190:71-82. PMID: 28535520.
      Citations:    Fields:    
    44. Bover J, Bailone L, López-Báez V, Benito S, Ciceri P, Galassi A, Cozzolino M. Osteoporosis, bone mineral density and CKD-MBD: treatment considerations. J Nephrol. 2017 Oct; 30(5):677-687. PMID: 28432640.
      Citations: 12     Fields:    Translation:Humans
    45. Di Lullo L, Barbera V, Bellasi A, Cozzolino M, Russo D, Otranto G, Santoboni F, Ronco C. [Non vitamin-K dependent oral anticoagulants (NOACs) in chronic kidney disease patients with non-valvular atrial fibrillation]. G Ital Nefrol. 2017 Apr; 34(2):58-73. PMID: 28682563.
      Citations:    Fields:    Translation:Humans
    46. Di Lullo L, Mangano M, Ronco C, Barbera V, De Pascalis A, Bellasi A, Russo D, Di Iorio B, Cozzolino M. The treatment of type 2 diabetes mellitus in patients with chronic kidney disease: What to expect from new oral hypoglycemic agents. Diabetes Metab Syndr. 2017 Nov; 11 Suppl 1:S295-S305. PMID: 28292575.
      Citations: 5     Fields:    Translation:HumansAnimals
    47. Bellasi A, Mangano M, Galassi A, Cozzolino M. [CKD-MBD, cardiovascular involvement and prognosis]. G Ital Nefrol. 2017 Mar; 34(Suppl 69):150-161. PMID: 28682036.
      Citations: 2     Fields:    Translation:Humans
    48. Di Lullo L, Barbera V, Bellasi A, Cozzolino M, Russo D, Otranto G, Santoboni F, Ronco C. [NOACs and Chronic kidney disease]. G Ital Nefrol. 2017 Mar; 34(Suppl 69):188-204. PMID: 28682039.
      Citations:    Fields:    Translation:Humans
    49. Bellasi A, Galassi A, Mangano M, Di Lullo L, Cozzolino M. Vitamin D Metabolism and Potential Effects of Vitamin D Receptor Modulation in Chronic Kidney Disease. Curr Drug Metab. 2017; 18(7):680-688. PMID: 28460623.
      Citations: 1     Fields:    Translation:HumansAnimals
    50. Di Lullo L, Ronco C, Barbera V, Cozzolino M, Santoboni F, Villani A, De Pascalis A, Bellasi A. [Newer anti - diabetic therapies and chronic kidney disease]. G Ital Nefrol. 2017 Jan-Feb; 34(1). PMID: 28177092.
      Citations:    Fields:    Translation:Humans
    51. Vervloet M, Cozzolino M. Vascular calcification in chronic kidney disease: different bricks in the wall? Kidney Int. 2017 04; 91(4):808-817. PMID: 27914706.
      Citations: 68     Fields:    Translation:HumansAnimalsCells
    52. Vervloet MG, Sezer S, Massy ZA, Johansson L, Cozzolino M, Fouque D. The role of phosphate in kidney disease. Nat Rev Nephrol. 2017 Jan; 13(1):27-38. PMID: 27867189.
      Citations: 41     Fields:    Translation:HumansAnimals
    53. Kanbay M, Vervloet M, Cozzolino M, Siriopol D, Covic A, Goldsmith D, Solak Y. Novel Faces of Fibroblast Growth Factor 23 (FGF23): Iron Deficiency, Inflammation, Insulin Resistance, Left Ventricular Hypertrophy, Proteinuria and Acute Kidney Injury. Calcif Tissue Int. 2017 03; 100(3):217-228. PMID: 27826644.
      Citations: 15     Fields:    Translation:HumansAnimals
    54. Di Lullo L, Bellasi A, Russo D, Cozzolino M, Ronco C. Cardiorenal acute kidney injury: Epidemiology, presentation, causes, pathophysiology and treatment. Int J Cardiol. 2017 Jan 15; 227:143-150. PMID: 27863290.
      Citations: 10     Fields:    Translation:Humans
    55. Bellasi A, Di Micco L, Santoro D, Marzocco S, De Simone E, Cozzolino M, Di Lullo L, Guastaferro P, Di Iorio B. Correction of metabolic acidosis improves insulin resistance in chronic kidney disease. BMC Nephrol. 2016 10 22; 17(1):158. PMID: 27770799.
      Citations: 24     Fields:    Translation:Humans
    56. Ciceri P, Elli F, Braidotti P, Falleni M, Tosi D, Bulfamante G, Block GA, Cozzolino M. Iron citrate reduces high phosphate-induced vascular calcification by inhibiting apoptosis. Atherosclerosis. 2016 11; 254:93-101. PMID: 27716569.
      Citations: 20     Fields:    Translation:AnimalsCells
    57. Cianciolo G, Cozzolino M. FGF23 in kidney transplant: the strange case of Doctor Jekyll and Mister Hyde. Clin Kidney J. 2016 Oct; 9(5):665-8. PMID: 27679712.
      Citations: 5     
    58. Bellasi A, Cozzolino M, Russo D, Molony D, Di Iorio B. Cinacalcet but not vitamin D use modulates the survival benefit associated with sevelamer in the INDEPENDENT study. Clin Nephrol. 2016 Sep; 86(9):113-24. PMID: 27443567.
      Citations: 5     Fields:    Translation:Humans
    59. Cozzolino M, Mangano M, Magagnoli L, Di Lullo L, Galassi A, Brancaccio D, Bellasi A. [Iron-based Phosphate Binders for ESRD Patients]. G Ital Nefrol. 2016 Jul-Aug; 33(4). PMID: 27545638.
      Citations:    Fields:    Translation:Humans
    60. Bellasi A, Di Lullo L, Melfa G, Minoretti C, Ratti C, Campana C, Volpi M, Mangano S, Di Iorio B, Cozzolino M. [New oral anticoagulants (NOAC) in nephrology]. G Ital Nefrol. 2016 Jul-Aug; 33(4). PMID: 27545637.
      Citations:    Fields:    Translation:Humans
    61. Ciceri P, Elli F, Cappelletti L, Tosi D, Savi F, Bulfamante G, Cozzolino M. Osteonectin (SPARC) Expression in Vascular Calcification: In Vitro and Ex Vivo Studies. Calcif Tissue Int. 2016 11; 99(5):472-480. PMID: 27339669.
      Citations: 7     Fields:    Translation:Animals
    62. Cianciolo G, Galassi A, Capelli I, Angelini ML, La Manna G, Cozzolino M. Vitamin D in Kidney Transplant Recipients: Mechanisms and Therapy. Am J Nephrol. 2016; 43(6):397-407. PMID: 27229347.
      Citations: 10     Fields:    Translation:Humans
    63. Di Lullo L, Bellasi A, Barbera V, Cozzolino M, Russo D, De Pascalis A, Santoboni F, Villani A, De Rosa S, Colafelice M, Russo L, Ronco C. [Acute Kidney Injury, Type - 3 cardiorenal syndrome, Biomarkers, Renal Replacement Therapy]. G Ital Nefrol. 2016 May-Jun; 33(3). PMID: 27374388.
      Citations:    Fields:    Translation:Humans
    64. Morrone LF, Bolasco P, Camerini C, Cianciolo G, Cupisti A, Galassi A, Mazzaferro S, Russo D, Russo L, Cozzolino M. Vitamin D in patients with chronic kidney disease: a position statement of the Working Group "Trace Elements and Mineral Metabolism" of the Italian Society of Nephrology. J Nephrol. 2016 Jun; 29(3):305-328. PMID: 27062486.
      Citations: 11     Fields:    Translation:Humans
    65. Cozzolino M, Elli F, Carugo S, Ciceri P. Secondary Hyperparathyroidism in End-Stage Renal Disease: No Longer a Matter for Surgeons? Blood Purif. 2016; 42(1):44-8. PMID: 27035129.
      Citations: 2     Fields:    Translation:Humans
    66. Massy ZA, Nistor I, Apetrii M, Brandenburg VM, Bover J, Evenepoel P, Goldsmith D, Mazzaferro S, Urena-Torres P, Vervloet MG, Cozzolino M, Covic A, Era-Edta OB. Magnesium-based interventions for normal kidney function and chronic kidney disease. Magnes Res. 2016 Apr 01; 29(4):126-140. PMID: 28007671.
      Citations: 7     Fields:    Translation:HumansAnimals
    67. Brandenburg VM, Evenepoel P, Floege J, Goldsmith D, Kramann R, Massy Z, Mazzaferro S, Schurgers LJ, Sinha S, Torregrosa V, Ureña-Torres P, Vervloet M, Cozzolino M. Lack of evidence does not justify neglect: how can we address unmet medical needs in calciphylaxis? Nephrol Dial Transplant. 2016 08; 31(8):1211-9. PMID: 27005994.
      Citations: 16     Fields:    Translation:Humans
    68. Cozzolino M, Carugo S. Low Dialysate Calcium: Between Low Arterial Calcification and Improved Low Bone Turnover. Blood Purif. 2016; 42(1):1-2. PMID: 26901861.
      Citations: 1     Fields:    Translation:Humans
    69. Centola M, Lucreziotti S, Salerno-Uriarte D, Sponzilli C, Ferrante G, Acquaviva R, Castini D, Spina M, Lombardi F, Cozzolino M, Carugo S. A comparison between two different definitions of contrast-induced acute kidney injury in patients with ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention. Int J Cardiol. 2016 May 01; 210:4-9. PMID: 26921538.
      Citations: 10     Fields:    Translation:Humans
    70. Cianciolo G, Capelli I, Cappuccilli M, Schillaci R, Cozzolino M, La Manna G. Calcifying circulating cells: an uncharted area in the setting of vascular calcification in CKD patients. Clin Kidney J. 2016 Apr; 9(2):280-6. PMID: 26985381.
      Citations: 16     
    71. Malindretos P, Cozzolino M. Phosphate binders, past - present - future. A critical appraisal. Expert Opin Pharmacother. 2016; 17(3):297-300. PMID: 26679256.
      Citations: 1     Fields:    
    72. Russo D, Capuano A, Cozzolino M, Napolitano P, Mosella F, Russo L, Saviano C, Zoccali C. Multimodal treatment of calcific uraemic arteriolopathy (calciphylaxis): a case series. Clin Kidney J. 2016 Feb; 9(1):108-12. PMID: 26798470.
      Citations: 9     
    73. Cozzolino M, Pasquali M. Where is the link between mineral bone markers and cardiovascular disease in CKD? Clin Kidney J. 2015 Dec; 8(6):729-31. PMID: 26613032.
      Citations: 2     
    74. Cozzolino M, Covic A, Martinez-Placencia B, Xynos K. Treatment Failure of Active Vitamin D Therapy in Chronic Kidney Disease: Predictive Factors. Am J Nephrol. 2015; 42(3):228-36. PMID: 26439891.
      Citations: 1     Fields:    Translation:Humans
    75. Ciceri P, Elli F, Cappelletti L, Tosi D, Braidotti P, Bulfamante G, Cozzolino M. A new in vitro model to delay high phosphate-induced vascular calcification progression. Mol Cell Biochem. 2015 Dec; 410(1-2):197-206. PMID: 26346159.
      Citations: 6     Fields:    Translation:AnimalsCells
    76. Cozzolino M. New endocrine biomarkers and cardiovascular disease: is it time for routinely screening? Clin Chem Lab Med. 2015 Sep 01; 53(10):1481-2. PMID: 25781699.
      Citations:    Fields:    Translation:HumansCells
    77. Bover J, Ureña P, Ruiz-García C, daSilva I, Lescano P, del Carpio J, Ballarín J, Cozzolino M. Clinical and Practical Use of Calcimimetics in Dialysis Patients With Secondary Hyperparathyroidism. Clin J Am Soc Nephrol. 2016 Jan 07; 11(1):161-74. PMID: 26224878.
      Citations: 15     Fields:    Translation:Humans
    78. Brandenburg V, Adragao T, van Dam B, Evenepoel P, Frazão JM, Ketteler M, Mazzaferro S, Urena Torres P, Ramos R, Torregrosa JV, Cozzolino M. Blueprint for a European calciphylaxis registry initiative: the European Calciphylaxis Network (EuCalNet). Clin Kidney J. 2015 Oct; 8(5):567-71. PMID: 26413282.
      Citations: 2     
    79. Di Lullo L, Barbera V, Santoboni A, Bellasi A, Cozzolino M, De Pascalis A, Rivera R, Balducci A, Russo D, Ronco C. [Troponins and chronic kidney disease]. G Ital Nefrol. 2015 Jul-Aug; 32(4). PMID: 26252257.
      Citations: 3     Fields:    Translation:Humans
    80. Goldsmith D, Covic A, Vervloet M, Cozzolino M, Nistor I. Should patients with CKD stage 5D and biochemical evidence of secondary hyperparathyroidism be prescribed calcimimetic therapy? An ERA-EDTA position statement. Nephrol Dial Transplant. 2015 May; 30(5):698-700. PMID: 25928337.
      Citations: 10     Fields:    Translation:Humans
    81. Bover J, Evenepoel P, Ureña-Torres P, Vervloet MG, Brandenburg V, Mazzaferro S, Covic A, Goldsmith D, Massy ZA, Cozzolino M. Pro: cardiovascular calcifications are clinically relevant. Nephrol Dial Transplant. 2015 Mar; 30(3):345-51. PMID: 25712934.
      Citations: 15     Fields:    Translation:Humans
    82. Bover J, Evenepoel P, Ureña-Torres P, Vervloet MG, Brandenburg V, Mazzaferro S, Covic A, Goldsmith D, Massy ZA, Cozzolino M. Opponent's comments. Nephrol Dial Transplant. 2015 Mar; 30(3):357. PMID: 25712937.
      Citations: 1     Fields:    
    83. Cozzolino M, Tomlinson J, Walsh L, Bellasi A. Emerging drugs for secondary hyperparathyroidism. Expert Opin Emerg Drugs. 2015 Jun; 20(2):197-208. PMID: 25702624.
      Citations: 7     Fields:    Translation:HumansAnimals
    84. Messa P, Cozzolino M, Brancaccio D, Cannella G, Malberti F, Costanzo AM, di Luzio Paparatti U, Festa V, Gualberti G, Mazzaferro S. Effect of VDRA on survival in incident hemodialysis patients: results of the FARO-2 observational study. BMC Nephrol. 2015 Feb 06; 16:11. PMID: 25886515.
      Citations: 9     Fields:    Translation:Humans
    85. Cozzolino M. A renewed question in haemodialysis patients: should we correct low serum magnesium levels? Blood Purif. 2014; 38(3-4):242-3. PMID: 25573222.
      Citations:    Fields:    Translation:Humans
    86. Cozzolino M. The link between vitamin D, parathyroid hormone, and cardiovascular disease. J Cardiovasc Med (Hagerstown). 2015 Jan; 16(1):69-70. PMID: 25333373.
      Citations:    Fields:    Translation:Humans
    87. Roggeri DP, Cozzolino M, Mazzaferro S, Brancaccio D, Paoletti E, Roggeri A, Costanzo AM, di Luzio Paparatti U, Festa V, Messa P. Evaluating targets and costs of treatment for secondary hyperparathyroidism in incident dialysis patients: the FARO-2 study. Int J Nephrol Renovasc Dis. 2015; 8:1-6. PMID: 25565880.
      Citations: 2     
    88. Morrone LF, Cozzolino M. The beneficial impact of vitamin D treatment in CKD patients: what's next? Clin Kidney J. 2015 Feb; 8(1):38-40. PMID: 25713708.
      Citations: 3     
    89. Cozzolino M, Evenepoel P, Covic A. Introduction: Mineral bone disorder is a key player in chronic kidney disease. Semin Nephrol. 2014 Nov; 34(6):577. PMID: 25498376.
      Citations:    Fields:    Translation:Humans
    90. Olauson H, Vervloet MG, Cozzolino M, Massy ZA, Ureña Torres P, Larsson TE. New insights into the FGF23-Klotho axis. Semin Nephrol. 2014 Nov; 34(6):586-97. PMID: 25498378.
      Citations: 23     Fields:    Translation:HumansAnimals
    91. Brandenburg VM, Cozzolino M, Mazzaferro S. Calcific uremic arteriolopathy: a call for action. Semin Nephrol. 2014 Nov; 34(6):641-7. PMID: 25498382.
      Citations: 7     Fields:    Translation:Humans
    92. Cozzolino M, Messa P, Brancaccio D, Cannella G, Bolasco P, Di Luca M, Costanzo AM, Paparatti Ud, Festa V, Gualberti G, Mazzaferro S. Achievement of NKF/K-DOQI recommended target values for bone and mineral metabolism in incident hemodialysis patients: results of the FARO-2 cohort. Blood Purif. 2014; 38(1):37-45. PMID: 25277167.
      Citations: 10     Fields:    Translation:Humans
    93. Russo R, Ruospo M, Cozzolino M, De Nicola L, Icardi A, Paoletti E, Mazzaferro S. Effects of vitamin D on parathyroid hormone and clinical outcomes in peritoneal dialysis: a narrative review. J Nephrol. 2014 Oct; 27(5):483-94. PMID: 25012237.
      Citations: 3     Fields:    Translation:Humans
    94. Vervloet MG, Massy ZA, Brandenburg VM, Mazzaferro S, Cozzolino M, Ureña-Torres P, Bover J, Goldsmith D. Bone: a new endocrine organ at the heart of chronic kidney disease and mineral and bone disorders. Lancet Diabetes Endocrinol. 2014 May; 2(5):427-36. PMID: 24795256.
      Citations: 41     Fields:    Translation:Humans
    95. Cozzolino M. Which outcome in chronic kidney disease-mineral and bone disorder patients? Nephrourol Mon. 2014 May; 6(3):e18662. PMID: 25032145.
      Citations:    
    96. Maioli C, Cozzolino M, Gallieni M, Del Sole A, Tagliabue L, Strinchini A, Gaito S, Lecchi M, Cusi D, Lucignani G. Evaluation of renal function in elderly patients: performance of creatinine-based formulae versus the isotopic method using 99mTc-diethylene triamine pentaacetic acid. Nucl Med Commun. 2014 Apr; 35(4):416-22. PMID: 24457319.
      Citations: 4     Fields:    Translation:Humans
    97. Fouque D, Horne R, Cozzolino M, Kalantar-Zadeh K. Balancing nutrition and serum phosphorus in maintenance dialysis. Am J Kidney Dis. 2014 Jul; 64(1):143-50. PMID: 24819675.
      Citations: 16     Fields:    Translation:Humans
    98. Mazzaferro S, Cozzolino M. Editorial: vitamin D therapy: an update available experimental and clinical evidences to select " which D for which patient". Curr Vasc Pharmacol. 2014 Mar; 12(2):271. PMID: 24810041.
      Citations:    Fields:    Translation:HumansAnimals
    99. Galassi A, Cozzolino M. Magnesium: a renewed player of vascular ageing in diabetic CKD patients? Clin Kidney J. 2014 Apr; 7(2):93-6. PMID: 25852855.
      Citations: 3     
    100. Cozzolino M, Ureña-Torres P, Vervloet MG, Brandenburg V, Bover J, Goldsmith D, Larsson TE, Massy ZA, Mazzaferro S. Is chronic kidney disease-mineral bone disorder (CKD-MBD) really a syndrome? Nephrol Dial Transplant. 2014 Oct; 29(10):1815-20. PMID: 24516228.
      Citations: 28     Fields:    Translation:Humans
    101. Cozzolino M, Ketteler M, Martin KJ, Sharma A, Goldsmith D, Khan S. Paricalcitol- or cinacalcet-centred therapy affects markers of bone mineral disease in patients with secondary hyperparathyroidism receiving haemodialysis: results of the IMPACT-SHPT study. Nephrol Dial Transplant. 2014 Apr; 29(4):899-905. PMID: 24500308.
      Citations: 11     Fields:    Translation:HumansCTClinical Trials
    102. Carrero JJ, Cozzolino M. Nutritional therapy, phosphate control and renal protection. Nephron Clin Pract. 2014; 126(1):1-7. PMID: 24434650.
      Citations: 6     Fields:    Translation:Humans
    103. Cozzolino M, Funk F, Rakov V, Phan O, Teitelbaum I. Preclinical Pharmacokinetics, Pharmacodynamics and Safety of Sucroferric Oxyhydroxide. Curr Drug Metab. 2014; 15(10):953-65. PMID: 25658128.
      Citations: 12     Fields:    Translation:HumansAnimals
    104. Krueger T, Schlieper G, Schurgers L, Cornelis T, Cozzolino M, Jacobi J, Jadoul M, Ketteler M, Rump LC, Stenvinkel P, Westenfeld R, Wiecek A, Reinartz S, Hilgers RD, Floege J. Vitamin K1 to slow vascular calcification in haemodialysis patients (VitaVasK trial): a rationale and study protocol. Nephrol Dial Transplant. 2014 Sep; 29(9):1633-8. PMID: 24285427.
      Citations: 23     Fields:    Translation:Humans
    105. Icardi A, Sacco P, Tarroni A, Cappelletti L, Cozzolino M. [Role of inflammation on renal anaemia]. G Ital Nefrol. 2013 Nov-Dec; 30(6). PMID: 24402666.
      Citations: 1     Fields:    Translation:Humans
    106. Santorelli G, Bellasi A, Salari P, Lo Cicero A, Del Giudice L, Venturelli C, Francesco N, Cozzolino M, Galassi A. [A case of encapsulating peritoneal sclerosis after fifteen years of peritoneal dialysis with a favorable outcome]. G Ital Nefrol. 2013 Nov-Dec; 30(6). PMID: 24402663.
      Citations:    Fields:    Translation:Humans
    107. Foletti A, Cozzolino M. [A biophysical integrated approach to autoimmune nephrotic syndrome: case report]. Recenti Prog Med. 2013 Sep; 104(9):488-9. PMID: 24121945.
      Citations:    Fields:    Translation:Humans
    108. Locatelli F, Messa P, Bellasi A, Cozzolino M, Di Luca M, Garibotto G, Gesualdo L, Malberti F, Massimetti C, Mazzaferro S, Mereu MC, Morosetti M, Morrone LF, Panuccio V, Rapisarda F, Russo D, Schinella D. What can we learn from a statistically inconclusive trial? Consensus conference on the EVOLVE study results. G Ital Nefrol. 2013 Sep-Oct; 30(5). PMID: 24402624.
      Citations: 5     Fields:    Translation:Humans
    109. Minutolo R, Conte G, Cozzolino M, Polito P, Manno C, Di Iorio BR, Santoro D, Di Luca M, Nappi F, Feriozzi S, Sasso FC, De Nicola L. Conversion from epoetin and darbepoetin to C.E.R.A. in non-dialysis CKD patients: a multicenter Italian prospective study in nephrology practice. Blood Purif. 2013; 36(2):69-77. PMID: 23989045.
      Citations: 2     Fields:    Translation:Humans
    110. Galassi A, Bellasi A, Auricchio S, Papagni S, Cozzolino M. Which vitamin D in CKD-MBD? The time of burning questions. Biomed Res Int. 2013; 2013:864012. PMID: 23991423.
      Citations: 6     Fields:    Translation:HumansAnimals
    111. Bellasi A, Galassi A, Papagni S, Cozzolino M. Cardiac valve calcification: an immutable pathologic finding in chronic kidney disease? J Nephrol. 2013 Jul-Aug; 26(4):606-9. PMID: 23807642.
      Citations:    Fields:    Translation:Humans
    112. Bellasi A, Cozzolino M. Cinacalcet: the chemical parathyroidectomy? Clin Kidney J. 2013 Jun; 6(3):253-6. PMID: 26064483.
      Citations: 2     
    113. Bellasi A, Galassi A, Salvi P, Cozzolino M. Paricalcitol and cardiorenal outcome: from the IMPACT study to clinical practice. Blood Purif. 2013; 36(1):12-6. PMID: 23736115.
      Citations: 1     Fields:    Translation:Humans
    114. Mazzaferro S, Cozzolino M. Vitamin D Therapy: An Update. Curr Vasc Pharmacol. 2013 May 16. PMID: 23713870.
      Citations:    Fields:    
    115. Cozzolino M, Gentile G, Mazzaferro S, Brancaccio D, Ruggenenti P, Remuzzi G. Blood pressure, proteinuria, and phosphate as risk factors for progressive kidney disease: a hypothesis. Am J Kidney Dis. 2013 Nov; 62(5):984-92. PMID: 23664548.
      Citations: 12     Fields:    Translation:Humans
    116. Cozzolino M. Prevention and Treatment of CKD-MBD. Nephrourol Mon. 2013; 5(2):773-4. PMID: 23841044.
      Citations: 1     
    117. Ciceri P, Elli F, Brenna I, Volpi E, Brancaccio D, Cozzolino M. The calcimimetic calindol prevents high phosphate-induced vascular calcification by upregulating matrix GLA protein. Nephron Exp Nephrol. 2012; 122(3-4):75-82. PMID: 23548867.
      Citations: 3     Fields:    Translation:Animals
    118. Bellasi A, Cozzolino M, Adragao T, Di Iorio B, Russo D. Phosphate binders in moderate chronic kidney disease: where do we stand? J Nephrol. 2013 Nov-Dec; 26(6):993-1000. PMID: 23543481.
      Citations: 6     Fields:    Translation:Humans
    119. Icardi A, Paoletti E, De Nicola L, Mazzaferro S, Russo R, Cozzolino M. Renal anaemia and EPO hyporesponsiveness associated with vitamin D deficiency: the potential role of inflammation. Nephrol Dial Transplant. 2013 Jul; 28(7):1672-9. PMID: 23468534.
      Citations: 39     Fields:    Translation:HumansAnimals
    120. Ciceri P, Elli F, Brenna I, Volpi E, Romagnoli S, Tosi D, Braidotti P, Brancaccio D, Cozzolino M. Lanthanum prevents high phosphate-induced vascular calcification by preserving vascular smooth muscle lineage markers. Calcif Tissue Int. 2013 Jun; 92(6):521-30. PMID: 23416967.
      Citations: 8     Fields:    Translation:AnimalsCells
    121. Cozzolino M, Brunini F, Capone V, Ricca F, Kwaidri Y, Montanari E, Cusi D. [Role of vitamin D in the pathogenesis of chronic kidney disease]. Recenti Prog Med. 2013 Jan; 104(1):33-40. PMID: 23439539.
      Citations: 1     Fields:    Translation:Humans
    122. Cozzolino M, Bruschetta E, Cusi D, Montanari E, Giovenzana ME, Galassi A. Phosphate handling in CKD-MBD from stage 3 to dialysis and the three strengths of lanthanum carbonate. Expert Opin Pharmacother. 2012 Nov; 13(16):2337-53. PMID: 23033914.
      Citations: 4     Fields:    Translation:HumansAnimals
    123. Cozzolino M. Vitamin D: something new under the sun. Clin Kidney J. 2012 Aug; 5(4):285-7. PMID: 25874081.
      Citations: 3     
    124. Roggeri DP, Mazzaferro S, Brancaccio D, Cannella G, Messa P, Di Luca M, Morosetti M, Costanzo AM, di Luzio Paparatti U, Cornago D, Cozzolino M. Pharmacological control of secondary hyperparathyroidism in hemodialysis subjects: a cost consequences analysis of data from the FARO study. J Med Econ. 2012; 15(6):1110-7. PMID: 22702445.
      Citations: 3     Fields:    Translation:Humans
    125. Cozzolino M, Stucchi A, Rizzo MA, Brenna I, Elli F, Ciceri P, Bover J, Cusi D, Gallieni M. Phosphate control in peritoneal dialysis. Contrib Nephrol. 2012; 178:116-123. PMID: 22652727.
      Citations: 3     Fields:    Translation:Humans
    126. Cozzolino M, Brancaccio D, Cannella G, Messa P, Gesualdo L, Marangella M, LoDeserto C, Pozzato M, Rombolà G, Costanzo AM, di Luzio Paparatti U, Mazzaferro S. VDRA therapy is associated with improved survival in dialysis patients with serum intact PTH = 150 pg/mL: results of the Italian FARO Survey. Nephrol Dial Transplant. 2012 Sep; 27(9):3588-94. PMID: 22523119.
      Citations: 19     Fields:    Translation:Humans
    127. Ketteler M, Martin KJ, Wolf M, Amdahl M, Cozzolino M, Goldsmith D, Sharma A, Marx S, Khan S. Paricalcitol versus cinacalcet plus low-dose vitamin D therapy for the treatment of secondary hyperparathyroidism in patients receiving haemodialysis: results of the IMPACT SHPT study. Nephrol Dial Transplant. 2012 Aug; 27(8):3270-8. PMID: 22387567.
      Citations: 26     Fields:    Translation:HumansCTClinical Trials
    128. Cozzolino M. [FGF-23 causes left ventricular hypertrophy!]. G Ital Nefrol. 2012 Mar-Apr; 29(2):142. PMID: 22538939.
      Citations:    Fields:    Translation:Humans
    129. Cozzolino M, Rizzo MA, Stucchi A, Cusi D, Gallieni M. Sevelamer for hyperphosphataemia in kidney failure: controversy and perspective. Ther Adv Chronic Dis. 2012 Mar; 3(2):59-68. PMID: 23251769.
      Citations: 8     
    130. Ronco C, Cozzolino M. Mineral metabolism abnormalities and vitamin D receptor activation in cardiorenal syndromes. Heart Fail Rev. 2012 Mar; 17(2):211-20. PMID: 21327712.
      Citations: 9     Fields:    Translation:Humans
    131. Brancaccio D, Rivolta E, Cozzolino M. Encephalopathy in a dialysis patient treated with lanthanum carbonate (LC). Clin Kidney J. 2012 Feb; 5(1):81. PMID: 26069761.
      Citations:    
    132. Ciceri P, Volpi E, Brenna I, Elli F, Borghi E, Brancaccio D, Cozzolino M. The combination of lanthanum chloride and the calcimimetic calindol delays the progression of vascular smooth muscle cells calcification. Biochem Biophys Res Commun. 2012 Feb 24; 418(4):770-3. PMID: 22310712.
      Citations: 5     Fields:    Translation:AnimalsCells
    133. Cozzolino M, Bruschetta E, Stucchi A, Ronco C, Cusi D. Role of vitamin d receptor activators in cardio-renal syndromes. Semin Nephrol. 2012 Jan; 32(1):63-9. PMID: 22365164.
      Citations: 3     Fields:    Translation:Humans
    134. Costanzo MR, Cozzolino M, Aspromonte N, Mistrorigo F, Valle R, Ronco C. Extracorporeal ultrafiltration in heart failure and cardio-renal syndromes. Semin Nephrol. 2012 Jan; 32(1):100-11. PMID: 22365168.
      Citations:    Fields:    Translation:Humans
    135. Vezzoli G, Terranegra A, Rainone F, Arcidiacono T, Cozzolino M, Aloia A, Dogliotti E, Cusi D, Soldati L. Calcium-sensing receptor and calcium kidney stones. J Transl Med. 2011 Nov 22; 9:201. PMID: 22107799.
      Citations: 15     Fields:    Translation:Humans
    136. Mazzaferro S, Pasquali M, Cozzolino M. Treatment of cardiovascular calcification in uremia. Curr Vasc Pharmacol. 2011 Nov; 9(6):741-9. PMID: 21824104.
      Citations: 2     Fields:    Translation:HumansAnimals
    137. Cozzolino M, Galassi A, Apetrii M, Covic A. What would we like to know, and what do we not know about fibroblast growth factor 23? J Nephrol. 2011 Nov-Dec; 24(6):696-706. PMID: 21786227.
      Citations: 3     Fields:    Translation:Humans
    138. Ketteler M, Martin KJ, Cozzolino M, Goldsmith D, Sharma A, Khan S, Dumas E, Amdahl M, Marx S, Audhya P. Paricalcitol versus cinacalcet plus low-dose vitamin D for the treatment of secondary hyperparathyroidism in patients receiving haemodialysis: study design and baseline characteristics of the IMPACT SHPT study. Nephrol Dial Transplant. 2012 May; 27(5):1942-9. PMID: 21931122.
      Citations: 8     Fields:    Translation:Humans
    139. Cozzolino M. [Prevention of vascular calcification: the role of magnesium]. G Ital Nefrol. 2011 Sep-Oct; 28(5):472. PMID: 22028259.
      Citations:    Fields:    Translation:HumansAnimalsCells
    140. Bover J, Cozzolino M. Mineral and bone disorders in chronic kidney disease and end-stage renal disease patients: new insights into vitamin D receptor activation. Kidney Int Suppl (2011). 2011 Sep; 1(4):122-129. PMID: 25018911.
      Citations: 4     
    141. Brancaccio D, Cozzolino M, Cannella G, Messa P, Bonomini M, Cancarini G, Caruso MR, Cascone C, Costanzo AM, di Luzio Paparatti U, Mazzaferro S. Secondary hyperparathyroidism in chronic dialysis patients: results of the Italian FARO survey on treatment and mortality. Blood Purif. 2011; 32(2):124-32. PMID: 21625082.
      Citations: 10     Fields:    Translation:HumansCTClinical Trials
    142. Ciceri P, Volpi E, Brenna I, Arnaboldi L, Neri L, Brancaccio D, Cozzolino M. Combined effects of ascorbic acid and phosphate on rat VSMC osteoblastic differentiation. Nephrol Dial Transplant. 2012 Jan; 27(1):122-7. PMID: 21613385.
      Citations: 11     Fields:    Translation:AnimalsCells
    143. Cozzolino M, Ronco C. The impact of paricalcitol on left ventricular hypertrophy. Contrib Nephrol. 2011; 171:161-165. PMID: 21625106.
      Citations: 4     Fields:    Translation:HumansAnimals
    144. Cozzolino M, Brenna I, Volpi E, Ciceri P, Mehmeti F, Cusi D. Restoring the physiology of vitamin D receptor activation and the concept of selectivity. Contrib Nephrol. 2011; 171:151-156. PMID: 21625104.
      Citations: 1     Fields:    Translation:HumansAnimals
    145. Cozzolino M, Brenna I, Ciceri P, Volpi E, Cusi D, Brancaccio D. Vascular calcification in chronic kidney disease: a changing scenario. J Nephrol. 2011 May-Jun; 24 Suppl 18:S3-10. PMID: 21623576.
      Citations: 3     Fields:    Translation:Humans
    146. Cozzolino M, Mazzaferro S, Messa P. New insights into the role of calcium-sensing receptor activation. J Nephrol. 2011 May-Jun; 24 Suppl 18:S38-41. PMID: 21623581.
      Citations: 3     Fields:    Translation:Humans
    147. Brancaccio D, Cozzolino M. CKD-MBD: an endless story. J Nephrol. 2011 May-Jun; 24 Suppl 18:S42-8. PMID: 21623582.
      Citations: 4     Fields:    Translation:Humans
    148. Cozzolino M, Mehmeti F, Ciceri P, Volpi E, Stucchi A, Brenna I, Cusi D. The Effect of Paricalcitol on Vascular Calcification and Cardiovascular Disease in Uremia: Beyond PTH Control. Int J Nephrol. 2011; 2011:269060. PMID: 21603158.
      Citations: 5     
    149. Brandenburg VM, Cozzolino M, Ketteler M. Calciphylaxis: a still unmet challenge. J Nephrol. 2011 Mar-Apr; 24(2):142-8. PMID: 21337312.
      Citations: 25     Fields:    Translation:Humans
    150. Cozzolino M. [When is calcium bad for CKD patients?]. G Ital Nefrol. 2011 Jan-Feb; 28(1):9. PMID: 21341235.
      Citations:    Fields:    Translation:Humans
    151. Cozzolino M, Mazzaferro S, Brandenburg V. The treatment of hyperphosphataemia in CKD: calcium-based or calcium-free phosphate binders? Nephrol Dial Transplant. 2011 Feb; 26(2):402-7. PMID: 21079194.
      Citations: 9     Fields:    Translation:Humans
    152. Cozzolino M, Biondi ML, Banfi E, Riser BL, Mehmeti F, Cusi D, Gallieni M. CCN2 (CTGF) gene polymorphism is a novel prognostic risk factor for cardiovascular outcomes in hemodialysis patients. Blood Purif. 2010; 30(4):272-6. PMID: 21071938.
      Citations: 7     Fields:    Translation:Humans
    153. Cozzolino M, Missaglia E, Ortiz A, Bellasi A, Adragao T, Apostolous T, Vescovo G, Gallieni M. [Vascular calcification in chronic kidney disease]. Recenti Prog Med. 2010 Nov; 101(11):442-52. PMID: 21197764.
      Citations: 4     Fields:    Translation:Humans
    154. Cozzolino M, Mehmeti F, Bonelli F, Ronga C, Musetti C, Missaglia E, Stucchi A, Colombo F, Tavecchia M, Cuoccio P, Brenna I, Volpi E, Ciceri P, Cusi D. [Cardioprotective effect of vitamin D in nondialyzed patients with stage 3-5 CKD]. G Ital Nefrol. 2010 Nov-Dec; 27 Suppl 52:S27-31. PMID: 21132659.
      Citations:    Fields:    Translation:Humans
    155. Cozzolino M, Brandenburg V. Warfarin: to use or not to use in chronic kidney disease patients? J Nephrol. 2010 Nov-Dec; 23(6):648-52. PMID: 20349408.
      Citations: 6     Fields:    Translation:Humans
    156. Cozzolino M. The control of hyperphosphatemia in renal failure: between vascular calcification and inflammation. Blood Purif. 2010; 30(3):159-60. PMID: 20861618.
      Citations:    Fields:    Translation:Humans
    157. Pontoriero G, Cozzolino M, Locatelli F, Brancaccio D. CKD patients: the dilemma of serum PTH levels. Nephron Clin Pract. 2010; 116(4):c263-8. PMID: 20639672.
      Citations: 6     Fields:    Translation:Humans
    158. Cozzolino M, Ketteler M, Zehnder D. The vitamin D system: a crosstalk between the heart and kidney. Eur J Heart Fail. 2010 Oct; 12(10):1031-41. PMID: 20605845.
      Citations: 22     Fields:    Translation:Humans
    159. Cozzolino M. [VDR and CaSR: from parathyroids to arteries]. G Ital Nefrol. 2010 Jul-Aug; 27(4):334. PMID: 20672226.
      Citations:    Fields:    Translation:Humans
    160. Cozzolino M, Ronga C, Cusi D. [Anticoagulant therapy in patients with atrial fibrillation on dialysis: between the risk of hemorrhage and vascular calcification]. G Ital Nefrol. 2010 May-Jun; 27(3):237-9. PMID: 20540016.
      Citations:    Fields:    Translation:Humans
    161. Cozzolino M, Mazzaferro S. The fibroblast growth factor 23: a new player in the field of cardiovascular, bone and renal disease. Curr Vasc Pharmacol. 2010 May; 8(3):404-11. PMID: 20180772.
      Citations: 12     Fields:    Translation:HumansAnimals
    162. Cozzolino M, Biondi ML, Galassi A, Cusi D, Brancaccio D, Gallieni M. Vascular calcification and cardiovascular outcome in dialysis patients: the role of gene polymorphisms. Blood Purif. 2010; 29(4):347-51. PMID: 20357434.
      Citations: 5     Fields:    Translation:Humans
    163. Gallieni M, Olivi L, Mezzina N, Cozzolino M, Cusi D. [Renal effects of combined anti-hypertensive treatments]. Recenti Prog Med. 2010 Feb; 101(2):70-7. PMID: 20433005.
      Citations:    Fields:    Translation:Humans
    164. Cozzolino M. [KDIGO on CKD-MBD: a new classification for an old problem?]. G Ital Nefrol. 2009 Nov-Dec; 26(6):645. PMID: 19918741.
      Citations:    Fields:    Translation:Humans
    165. Cozzolino M. Emerging roles for osteoprotegerin and receptor activator of nuclear factor-kappaB in the vascular system. Blood Purif. 2009; 28(4):346-7. PMID: 19729903.
      Citations: 1     Fields:    Translation:Humans
    166. Brancaccio D, Bellasi A, Cozzolino M, Galassi A, Gallieni M. Arterial accelerated aging in dialysis patients: the clinical impact of vascular calcification. Curr Vasc Pharmacol. 2009 Jul; 7(3):374-80. PMID: 19601862.
      Citations: 8     Fields:    Translation:HumansAnimals
    167. Brancaccio D, Cozzolino M, Pasho S, Fallabrino G, Olivi L, Gallieni M. New acquisitions in therapy of secondary hyperparathyroidism in chronic kidney disease and peritoneal dialysis patients: role of vitamin D receptor activators. Contrib Nephrol. 2009; 163:219-226. PMID: 19494617.
      Citations: 1     Fields:    Translation:Humans
    168. Cozzolino M, Fallabrino G, Pasho S, Olivi L, Ciceri P, Volpi E, Gallieni M, Brancaccio D. Importance of vitamin D receptor activation in clinical practice. Contrib Nephrol. 2009; 163:213-218. PMID: 19494616.
      Citations: 2     Fields:    Translation:Humans
    169. Cozzolino M. The role of FGF-23 in CKD patients still needs to be clarified. Nephrol Dial Transplant. 2009 Aug; 24(8):2605; author reply 2605. PMID: 19474280.
      Citations:    Fields:    Translation:Humans
    170. Neri L, Rocca Rey LA, Gallieni M, Brancaccio D, Cozzolino M, Colombi A, Burroughs TE. Occupational stress is associated with impaired work ability and reduced quality of life in patients with chronic kidney failure. Int J Artif Organs. 2009 May; 32(5):291-8. PMID: 19569038.
      Citations: 9     Fields:    Translation:Humans
    171. Morrone LF, Mazzaferro S, Russo D, Aucella F, Cozzolino M, Facchini MG, Galfrè A, Malberti F, Mereu MC, Nordio M, Pertosa G, Santoro D. Interaction between parathyroid hormone and the Charlson comorbidity index on survival of incident haemodialysis patients. Nephrol Dial Transplant. 2009 Sep; 24(9):2859-65. PMID: 19369685.
      Citations: 8     Fields:    Translation:Humans
    172. Cozzolino M. Matrix-Gla protein and vascular calcification: the negative role of oral anticoagulant therapy. Thromb Haemost. 2009 Apr; 101(4):605-6. PMID: 19350099.
      Citations: 1     Fields:    Translation:HumansAnimalsCells
    173. Cozzolino M, Ciceri P, Volpi EM, Olivi L, Messa PG. Pathophysiology of calcium and phosphate metabolism impairment in chronic kidney disease. Blood Purif. 2009; 27(4):338-44. PMID: 19295196.
      Citations: 12     Fields:    Translation:Humans
    174. Messa P, Cerutti R, Brezzi B, Alfieri C, Cozzolino M. Calcium and phosphate control by dialysis treatments. Blood Purif. 2009; 27(4):360-8. PMID: 19295199.
      Citations: 4     Fields:    Translation:Humans
    175. Galassi A, Brancaccio D, Cozzolino M, Bellinghieri G, Buoncristiani U, Cavatorta F, D'Apice L, Di Iorio B, Gesualdo L, Gianni S, Ricciardi B, Russo D, Andreucci V. Awareness of hypertension and proteinuria in randomly selected patients in 11 Italian cities. A 2005 report of the National Kidney Foundation of Italy. J Clin Hypertens (Greenwich). 2009 Mar; 11(3):138-43. PMID: 19302425.
      Citations: 1     Fields:    Translation:HumansPHPublic Health
    176. Cozzolino M, Biondi ML, Galassi A, Turri O, Brancaccio D, Gallieni M. Matrix metalloproteinase-1 and matrix metalloproteinase-3 gene promoter polymorphisms are associated with mortality in haemodialysis patients. Nephrol Dial Transplant. 2009 Jul; 24(7):2207-12. PMID: 19221176.
      Citations: 3     Fields:    Translation:HumansCells
    177. Cozzolino M, Ketteler M. The link between bone and cardiovascular disease in CKD: new insights into pathogenesis and treatment. Int J Artif Organs. 2009 Feb; 32(2):65-6. PMID: 19363776.
      Citations: 1     Fields:    Translation:Humans
    178. Cozzolino M, Pasho S, Fallabrino G, Olivi L, Gallieni M, Brancaccio D. Pathogenesis of secondary hyperparathyroidism. Int J Artif Organs. 2009 Feb; 32(2):75-80. PMID: 19363778.
      Citations: 4     Fields:    Translation:HumansAnimals
    179. Gallieni M, Cozzolino M, Fallabrino G, Pasho S, Olivi L, Brancaccio D. Vitamin D: physiology and pathophysiology. Int J Artif Organs. 2009 Feb; 32(2):87-94. PMID: 19363780.
      Citations: 14     Fields:    Translation:Humans
    180. Cozzolino M, Gallieni M, Brancaccio D. Inflammation and vascular calcification in chronic kidney disease: the role of Fetuin-A. Cytokine. 2009 Feb; 45(2):70-1. PMID: 19135384.
      Citations:    Fields:    Translation:HumansAnimals
    181. Cozzolino M, Gallieni M, Pasho S, Fallabrino G, Ciceri P, Volpi EM, Olivi L, Brancaccio D. Management of secondary hyperparathyroidism in the elderly patient with chronic kidney disease. Drugs Aging. 2009; 26(6):457-68. PMID: 19591520.
      Citations: 1     Fields:    Translation:Humans
    182. Gallieni M, Cozzolino M, Brancaccio D, Giovannini M. Renal outcomes in the ONTARGET study. Lancet. 2008 Dec 13; 372(9655):2019; author reply 2020-1. PMID: 19070732.
      Citations:    Fields:    Translation:Humans
    183. Cozzolino M, Brancaccio D. VDRAs versus calcimimetics: better safe than sorry? Kidney Int. 2008 Oct; 74(7):966; author reply 966-7. PMID: 18794826.
      Citations: 1     Fields:    Translation:HumansCells
    184. Gallieni M, Cozzolino M, Ronga C, Brancaccio D. Low-molecular-weight heparins should be used with caution in patients with chronic kidney disease. Nat Clin Pract Nephrol. 2008 Sep; 4(9):488-9. PMID: 18612327.
      Citations: 3     Fields:    Translation:Humans
    185. Gallieni M, Cozzolino M. Calcium and phosphate: serum levels versus body balance. Kidney Int. 2008 Jul; 74(2):246; author reply 246-7. PMID: 18591948.
      Citations: 1     Fields:    Translation:Humans
    186. Arcidiacono MV, Cozzolino M, Spiegel N, Tokumoto M, Yang J, Lu Y, Sato T, Lomonte C, Basile C, Slatopolsky E, Dusso AS. Activator protein 2alpha mediates parathyroid TGF-alpha self-induction in secondary hyperparathyroidism. J Am Soc Nephrol. 2008 Oct; 19(10):1919-28. PMID: 18579641.
      Citations: 5     Fields:    Translation:HumansAnimals
    187. Cozzolino M. [Vascular calcification: is there a link between hyperphosphatemia and hyperglycemia?]. G Ital Nefrol. 2008 May-Jun; 25(3):271. PMID: 18473292.
      Citations:    Fields:    Translation:Humans
    188. Cozzolino M, Brancaccio D. Emerging role for the vitamin D receptor activator (VDRA), paricalcitol, in the treatment of secondary hyperparathyroidism. Expert Opin Pharmacother. 2008 Apr; 9(6):947-54. PMID: 18377338.
      Citations: 3     Fields:    Translation:HumansAnimals
    189. Cozzolino M, Galassi A, Gallieni M, Brancaccio D. Pathogenesis and treatment of secondary hyperparathyroidism in dialysis patients: the role of paricalcitol. Curr Vasc Pharmacol. 2008 Apr; 6(2):148-53. PMID: 18393917.
      Citations: 6     Fields:    Translation:Humans
    190. Cozzolino M, Galassi A, Gallieni M, Brancaccio D. Successful use of low-dose intravenous paricalcitol in the treatment of severe secondary hyperparathyroidism in a haemodialysis patient. NDT Plus. 2008 Jun; 1(3):148-50. PMID: 25983861.
      Citations:    
    191. Cozzolino M, Galassi A, Pasho S, Fallabrino G, Gallieni M, Brancaccio D. Preventive measures and new pharmacological approaches of calcium and phosphate disorders. Contrib Nephrol. 2008; 161:234-239. PMID: 18451682.
      Citations: 4     Fields:    Translation:Humans
    192. Cozzolino M, Mazzaferro S, Pugliese F, Brancaccio D. Vascular calcification and uremia: what do we know? Am J Nephrol. 2008; 28(2):339-46. PMID: 18046081.
      Citations: 18     Fields:    Translation:Humans
    193. Cozzolino M, Brancaccio D. Is PTH a risk factor for cardiovascular calcifications in haemodialysis? Nephrol Dial Transplant. 2008 Mar; 23(3):1067-8; author reply 1068-9. PMID: 18045828.
      Citations: 1     Fields:    Translation:Humans
    194. Cozzolino M, Biondi ML, Galassi A, Gallieni M, d'Eril GV, Brancaccio D. Gene polymorphisms and serum alpha-2-Heremans-Schmid levels in Italian haemodialysis patients. Am J Nephrol. 2007; 27(6):639-42. PMID: 17851232.
      Citations: 2     Fields:    Translation:Humans
    195. Cozzolino M, Brancaccio D. Optimising the treatment of hyperphosphatemia and vascular calcification in chronic kidney disease. Expert Opin Emerg Drugs. 2007 Sep; 12(3):341-3. PMID: 17874964.
      Citations: 1     Fields:    Translation:Humans
    196. Memoli B, De Bartolo L, Favia P, Morelli S, Lopez LC, Procino A, Barbieri G, Curcio E, Giorno L, Esposito P, Cozzolino M, Brancaccio D, Andreucci VE, d'Agostino R, Drioli E. Fetuin-A gene expression, synthesis and release in primary human hepatocytes cultured in a galactosylated membrane bioreactor. Biomaterials. 2007 Nov; 28(32):4836-44. PMID: 17706279.
      Citations: 4     Fields:    Translation:HumansCells
    197. Cozzolino M, Galassi A, Brancaccio D. Cinacalcet, paricalcitol, or both? Nephrol Dial Transplant. 2007 Oct; 22(10):3087; author reply 3087-8. PMID: 17623718.
      Citations: 1     Fields:    Translation:Humans
    198. Arcidiacono MV, Cozzolino M, Brancaccio D, Gallieni M, Lesma E, Carelli S, Gorio A, Di Giulio AM. A role for enhanced integrin and FAK expression in uremia-induced parathyroid hyperplasia. J Nephrol. 2007 Mar-Apr; 20(2):228-33. PMID: 17514628.
      Citations: 1     Fields:    Translation:HumansAnimals
    199. Cozzolino M. [Role of vitamin D and its analogues in dialysis patients: beyond PTH control]. G Ital Nefrol. 2007 Mar-Apr; 24(2):107. PMID: 17458822.
      Citations:    Fields:    Translation:Humans
    200. Russo D, Corrao S, Miranda I, Ruocco C, Manzi S, Elefante R, Brancaccio D, Cozzolino M, Biondi ML, Andreucci VE. Progression of coronary artery calcification in predialysis patients. Am J Nephrol. 2007; 27(2):152-8. PMID: 17312351.
      Citations: 23     Fields:    Translation:Humans
    201. Cozzolino M, Brancaccio D. Clinical consequences and novel therapy of hyperphosphatemia: Lanthanum carbonate for dialysis patients. Recent Pat Cardiovasc Drug Discov. 2007 Jan; 2(1):29-34. PMID: 18221100.
      Citations: 2     Fields:    Translation:Humans
    202. Brancaccio D, Cozzolino M, Galassi A, Chiarelli G, Butti A, Bellasi A, Rocca-Rey L, Volpi A, Anelli A, Zoni U, Fusaro M, Brambilla C, Missaglia E, Crovetto C, Russo M, Longhini C, Provenzano R, Incalcaterra F, Cerasola G, Li Vecchi M, Gallieni M. Management of secondary hyperparathyroidism in uremic patients: the role of the new vitamin D analogs. J Nephrol. 2007 Jan-Feb; 20(1):3-9. PMID: 17347966.
      Citations:    Fields:    Translation:Humans
    203. Cozzolino M, Brancaccio D. Lanthanum carbonate--new data on parathyroid hormone control without liver damage. Nephrol Dial Transplant. 2007 Feb; 22(2):316-8. PMID: 17151005.
      Citations:    Fields:    Translation:Humans
    204. Cozzolino M, Galassi A, Biondi ML, Turri O, Papagni S, Mongelli N, Civita L, Gallieni M, Brancaccio D. Serum fetuin-A levels link inflammation and cardiovascular calcification in hemodialysis patients. Am J Nephrol. 2006; 26(5):423-9. PMID: 16968979.
      Citations: 17     Fields:    Translation:Humans
    205. Cozzolino M, Gallieni M, Brancaccio D, Arcidiacono T, Bianchi G, Vezzoli G. Vitamin D retains an important role in the pathogenesis and management of secondary hyperparathyroidism in chronic renal failure. J Nephrol. 2006 Sep-Oct; 19(5):566-77. PMID: 17136683.
      Citations: 7     Fields:    Translation:HumansCells
    206. Cozzolino M, Galassi A, Biondi ML, Butti A, Russo M, Longhini C, Gallieni M, Brancaccio D. Decreased serum fetuin-A levels after a single haemodialysis session. Nephrol Dial Transplant. 2007 Jan; 22(1):290-1. PMID: 16921184.
      Citations:    Fields:    Translation:Humans
    207. Cozzolino M, Gallieni M, Galassi A, Brambilla C, Brancaccio D. Phosphate overload accelerates vascular aging in uremic patients. Heart Int. 2006; 2(1):6. PMID: 21977245.
      Citations:    
    208. Cozzolino M, Gallieni M, Brancaccio D. Vascular calcification in uremic conditions: new insights into pathogenesis. Semin Nephrol. 2006 Jan; 26(1):33-7. PMID: 16412823.
      Citations: 6     Fields:    Translation:Humans
    209. Cozzolino M, Gallieni M, Chiarelli G, Brancaccio D. Calcium and phosphate handling in peritoneal dialysis. Contrib Nephrol. 2006; 150:214-225. PMID: 16721013.
      Citations: 1     Fields:    Translation:Humans
    210. Brancaccio D, Biondi ML, Gallieni M, Turri O, Galassi A, Cecchini F, Russo D, Andreucci V, Cozzolino M. Matrix GLA protein gene polymorphisms: clinical correlates and cardiovascular mortality in chronic kidney disease patients. Am J Nephrol. 2005 Nov-Dec; 25(6):548-52. PMID: 16210837.
      Citations: 18     Fields:    Translation:Humans
    211. Cozzolino M, Brancaccio D, Gallieni M, Slatopolsky E. Pathogenesis of vascular calcification in chronic kidney disease. Kidney Int. 2005 Aug; 68(2):429-36. PMID: 16014020.
      Citations: 51     Fields:    Translation:Humans
    212. Cozzolino M, Lu Y, Sato T, Yang J, Suarez IG, Brancaccio D, Slatopolsky E, Dusso AS. A critical role for enhanced TGF-alpha and EGFR expression in the initiation of parathyroid hyperplasia in experimental kidney disease. Am J Physiol Renal Physiol. 2005 Nov; 289(5):F1096-102. PMID: 15998841.
      Citations: 18     Fields:    Translation:AnimalsCells
    213. Brancaccio D, Cozzolino M. The mechanism of calcium deposition in soft tissues. Contrib Nephrol. 2005; 149:279-286. PMID: 15876851.
      Citations: 6     Fields:    Translation:Humans
    214. Cozzolino M, Butti A, Chiarelli G, Rocca-Rey L, Santagostino G, Gallieni M, Brancaccio D. [Cardiovascular calcification and accelerated atherosclerosis in chronic kidney disease]. Ital Heart J Suppl. 2005 Jan; 6(1):25-8. PMID: 15776728.
      Citations:    Fields:    Translation:HumansAnimalsCells
    215. Cozzolino M, Brancaccio D, Gallieni M, Galassi A, Slatopolsky E, Dusso A. Pathogenesis of parathyroid hyperplasia in renal failure. J Nephrol. 2005 Jan-Feb; 18(1):5-8. PMID: 15772917.
      Citations: 10     Fields:    Translation:HumansAnimals
    216. Dusso A, Cozzolino M, Lu Y, Sato T, Slatopolsky E. 1,25-Dihydroxyvitamin D downregulation of TGFalpha/EGFR expression and growth signaling: a mechanism for the antiproliferative actions of the sterol in parathyroid hyperplasia of renal failure. J Steroid Biochem Mol Biol. 2004 May; 89-90(1-5):507-11. PMID: 15225829.
      Citations: 3     Fields:    Translation:HumansCells
    217. Cozzolino M, Gallieni M, Corsi C, Bastagli A, Brancaccio D. Management of calcium refilling post-parathyroidectomy in end-stage renal disease. J Nephrol. 2004 Jan-Feb; 17(1):3-8. PMID: 15151253.
      Citations: 7     Fields:    Translation:Humans
    218. Brancaccio D, Cozzolino M, Gallieni M. Hyperparathyroidism and anemia in uremic subjects: a combined therapeutic approach. J Am Soc Nephrol. 2004 Jan; 15 Suppl 1:S21-4. PMID: 14684666.
      Citations: 26     Fields:    Translation:Humans
    219. Cozzolino M, Staniforth ME, Liapis H, Finch J, Burke SK, Dusso AS, Slatopolsky E. Sevelamer hydrochloride attenuates kidney and cardiovascular calcifications in long-term experimental uremia. Kidney Int. 2003 Nov; 64(5):1653-61. PMID: 14531797.
      Citations: 32     Fields:    Translation:Animals
    220. Slatopolsky E, Cozzolino M, Lu Y, Finch J, Dusso A, Staniforth M, Wein Y, Webster J. Efficacy of 19-Nor-1,25-(OH)2D2 in the prevention and treatment of hyperparathyroid bone disease in experimental uremia. Kidney Int. 2003 Jun; 63(6):2020-7. PMID: 12753289.
      Citations: 19     Fields:    Translation:Animals
    221. Brancaccio D, Di Leo C, Bestetti A, Carpani P, Tagliabue L, Cozzolino M, Galassi A, Luigi Tarolo G, Gallieni M. Severe cortical and trabecular osteopenia in secondary hyperparathyroidism. Hemodial Int. 2003 Apr 01; 7(2):122-9. PMID: 19379351.
      Citations: 1     Fields:    
    222. Cozzolino M, Vidal M, Arcidiacono MV, Tebas P, Yarasheski KE, Dusso AS. HIV-protease inhibitors impair vitamin D bioactivation to 1,25-dihydroxyvitamin D. AIDS. 2003 Mar 07; 17(4):513-20. PMID: 12598771.
      Citations: 66     Fields:    Translation:HumansCells
    223. Brancaccio D, Cozzolino M, Gorio A, Di Giulio AM, Gallieni M. Bone disease in uremic patients: advances in PTH suppression. J Nephrol. 2002 Nov-Dec; 15 Suppl 6:S86-93. PMID: 12515379.
      Citations: 1     Fields:    Translation:Humans
    224. Slatopolsky E, Cozzolino M, Finch JL. Differential effects of 19-nor-1,25-(OH)(2)D(2) and 1alpha-hydroxyvitamin D(2) on calcium and phosphorus in normal and uremic rats. Kidney Int. 2002 Oct; 62(4):1277-84. PMID: 12234297.
      Citations: 12     Fields:    Translation:Animals
    225. Cozzolino M, Dusso AS, Liapis H, Finch J, Lu Y, Burke SK, Slatopolsky E. The effects of sevelamer hydrochloride and calcium carbonate on kidney calcification in uremic rats. J Am Soc Nephrol. 2002 Sep; 13(9):2299-308. PMID: 12191974.
      Citations: 25     Fields:    Translation:Animals
    226. Cordero JB, Cozzolino M, Lu Y, Vidal M, Slatopolsky E, Stahl PD, Barbieri MA, Dusso A. 1,25-Dihydroxyvitamin D down-regulates cell membrane growth- and nuclear growth-promoting signals by the epidermal growth factor receptor. J Biol Chem. 2002 Oct 11; 277(41):38965-71. PMID: 12181310.
      Citations: 31     Fields:    Translation:HumansAnimalsCells
    Cozzolino's Networks
    Click the
    Explore
    buttons for more information and interactive visualizations!
    Concepts (234)
    Explore
    _
    Co-Authors (82)
    Explore
    _
    Similar People (60)
    Explore
    _